Lantern Pharma Inc. · NASDAQ:LTRN
Lantern Pharma Inc. shareholders
As of Sep 30, 2026, 41 institutions reported holding Lantern Pharma Inc., 24.5% of its shares. Largest: Armistice Capital, LLC, Empery Asset Management, LP and CM Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Lantern Pharma Inc. | Change | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 1.04M | 6.5% | new | Nov 16, 2026 |
| Empery Asset Management, LP | 543K | 3.4% | −299K | Nov 16, 2026 |
| CM Management, LLC | 500K | 3.1% | no change | Nov 12, 2026 |
| Vanguard | 473K | 3.0% | −4,832 | Nov 13, 2026 |
| Renaissance Technologies | 368K | 2.3% | +77,368 | Nov 12, 2026 |
| BIOS Capital Management, LP | 236K | 1.5% | −13,502 | Nov 13, 2026 |
| Two Sigma | 142K | 0.89% | new | Nov 16, 2026 |
| UBS | 125K | 0.79% | +109K | Nov 10, 2026 |
| Geode Capital | 102K | 0.64% | −1,176 | Nov 6, 2026 |
| Westside Investment Management, Inc. | 47,850 | 0.30% | no change | Nov 2, 2026 |